Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas (original) (raw)
Johnson MD, Woodard A, Kim P, Frexes-Steed M (2001) Evidence for mitogen associated protein kinase activation and transduction of mitogenic signals from platelet derived growth factor in human meningioma cells. J Neurosurg 94:303–310 Google Scholar
Johnson MD, Okediji E, Woodard A, Toms SA (2002) Evidence for phosphatidylinositol 3-kinase Akt-p70S6K pathway activation and transduction of mitogenic signals by platelet derived growth factor in human meningioma cells. J Neurosurg 97:668–675 PubMedCAS Google Scholar
Bromberg J (2002) STAT proteins and oncogenesis. J Clin Invest 109:1139–1142 PubMedCAS Google Scholar
Johanson CE, Duncan JA III, Klinge PM, Brinker T, Stopa EG, Silverberg GD (2008) Multiplicity of cerebrospinal fluid functions: New challenges in health and Disease. Cerebrospinal Fluid Res 5:10. doi:10.1186/1743-8454-5-10 ArticlePubMedCAS Google Scholar
Jones NR, Rossi ML, Gregoriou M, Hughes JT (1990) Epidermal growth factor receptor expression in 72 meningiomas. Cancer 66:152–155. doi:10.1002/1097-0142(19900701)66:1<152::AID-CNCR2820660127>3.0.CO;2-5 ArticlePubMedCAS Google Scholar
Weisman AS, Raguet SS, Kelly PA (1987) Characterization of the epidermal growth factor receptor in human meningioma. Cancer Res 47:2172–2176 PubMedCAS Google Scholar
Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PML, Antoniades HN (1990) Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46:16–21. doi:10.1002/ijc.2910460106 ArticlePubMedCAS Google Scholar
Shamah SM, Alberta JA, Giannobile WV, Guha A, Kwon YK, Carroll RS, Black PM, Stiles CD et al (1997) Detection of activated platlet-derived growth factor receptors in human meningioma. Cancer Res 57:4141–4147 PubMedCAS Google Scholar
Adams EF, Schrell UMH, Thieruf P, White MC, Fahlbusch R (1991) Autocrine control of human meningioma proliferation: secretion of platelet-derived growth factor-like molecules. Int J Cancer 49:398–402. doi:10.1002/ijc.2910490315 ArticlePubMedCAS Google Scholar
Nordqvist AC, Peyrard M, Petterson H et al (1997) A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res 57:2611–2614 PubMedCAS Google Scholar
Watson MA, Gutmann DH, Peterson K et al (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161:665–672 PubMedCAS Google Scholar
Magrassi L, De-Fraja C, Conti L, Butti G, Infuso L, Govoni S et al (1999) Expression of the JAK and STAT superfamilies in human meningiomas. J Neurosurg 91:440–446 ArticlePubMedCAS Google Scholar
Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C et al (2005) Different activation of mitogen activated protein kinase and Akt signalling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11:4074–4082. doi:10.1158/1078-0432.CCR-04-2550 ArticlePubMedCAS Google Scholar
Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Tumours of the nervous system. WHO Press, Geneva, Switzerland, pp 164–172 Google Scholar
Klampfer L (2006) Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 6:107–121. doi:10.2174/156800906776056491 ArticlePubMedCAS Google Scholar
Germain D, Frank DA (2007) Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 13:5665–5669. doi:10.1158/1078-0432.CCR-06-2491 ArticlePubMedCAS Google Scholar
Garcia R, Bowman TL, Niu G et al (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513. doi:10.1038/sj.onc.1204349 ArticlePubMedCAS Google Scholar
Barnett SF, Bilodeau MT, Lindsley CW (2005) The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress toward target validation. Curr Top Med Chem 5:109–125. doi:10.2174/1568026053507714 ArticlePubMedCAS Google Scholar
Shayesteh L, Lu Y, Kuo W-L, Baldocchi R, Godfrey T, Collins C et al (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99–102. doi:10.1038/5042 ArticlePubMedCAS Google Scholar
Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL et al (2001) AKT1/PKB alpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 159:431–437 PubMedCAS Google Scholar
Brognard J, Clark AS, Ni Y, Dennis PA (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61:3986–3997 PubMedCAS Google Scholar
Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Herman P et al (2004) EGFR mutations in lung cancer: correlation with clinical response to Gefitinib therapy. Science 304:1497–1500. doi:10.1126/science.1099314 ArticlePubMedCAS Google Scholar
Witzig TE, Kaufmann SH (2006) Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies. Curr Treat Options Oncol 7:285–294. doi:10.1007/s11864-006-0038-1 ArticlePubMed Google Scholar
Gire V, Marshall C, Wynford-Thomas D (2000) PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS. Oncogene 19:2269–2276. doi:10.1038/sj.onc.1203544 ArticlePubMedCAS Google Scholar
Walker TR, Moore SM, Lawson MF, Panettieri RA, Chilvers ER (1998) Platelet-derived growth factor-BB and thrombin activate phophoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol Pharmacol 54:1007–1015 PubMedCAS Google Scholar
Stommel JM, Kimmelman AC, Ying H et al (2007) Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318:287–290. doi:10.1126/science.1142946 ArticlePubMedCAS Google Scholar
Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D et al (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of heptocellular carcinomas cells. Cancer Res 67:2497–2507. doi:10.1158/0008-5472.CAN-06-3075 ArticlePubMedCAS Google Scholar
Nakamura JL, Karlsson A, Arvold ND, Gottschalk Ar, Pieper RO, Stokoe D et al (2005) PKB/Akt mediates radiosensitization by signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol 71:215–222. doi:10.1007/s11060-004-1718-y ArticlePubMedCAS Google Scholar
Wang MY, Lu KV, Dia EQ et al (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN intact glioblastoma cells. Cancer Res 66:7864–7869. doi:10.1158/0008-5472.CAN-04-4392 ArticlePubMedCAS Google Scholar